Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAVIGATOR phase 3 trial of tezepelumab in adults with severe uncontrolled asthma
MOH_2017-12-17_002037Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Dec 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Tezepelumab with Placebo (2 arms). Started Dec 2017; status: recruiting.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on MOH_2017-12-17_002037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-12-17_002037.